1 Product identity

Ingredient risk

1 ingredient to use with caution

Anavar

Name: Anavar
Brand: Hi-Tech Pharmaceuticals

BrandHi-Tech Pharmaceuticals→Other Combinations Tablet or Pill 12 ingredients 1 caution DSLD #10293

Net contents: 180 ct

Target: Adults and Children 4 years and above

DSLD entry: 2012-06-25

2 Ingredients (12)

IngredientGroupSafety

Proprietary Blend with Extend-Rx(TM) Technology——

Dextrose, AgglomeratedGlucose—

Microcrystalline CelluloseCellulose—

Hydroxypropyl CelluloseHydroxypropylcellulose—

Hydroxypropyl MethylcelluloseHypromellose—

Dicalcium PhosphateCalciumConditionally Safe

Sodium Starch GlycolateSodium Starch Glycolate—

StarchStarch—

Magnesium StearateMagnesium stearateUse with Caution

Stearic AcidStearic Acid—

PovidonePovidone—

SilicaSiliconGenerally Safe

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Calcium — Conditionally Safe

⚠ Cardiovascular risk debated >1,000 mg/day

⚠ Kidney stones

Sodium — Limited Evidence

⚠ Hypertension

⚠ Fluid retention

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

Silicon — Generally Safe

⚠ Very low toxicity

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID10293

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2012-06-25

6 More from Hi-Tech Pharmaceuticals

View Hi-Tech Pharmaceuticals Safety Scorecard → 50 products

Allergy-Rx Anavar-PCr Tropical Punch Flavor Attention Link Bulasterone Caralluma Fimbriata 20:1 extract 500 mg Choledrene

7 Cite this page

Vancouver

Pkhakadze G. Anavar — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/anavar-10293/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG